Baseline fracture risk in men with prostate cancer starting the STAMPEDE trial
Name:
mdz248.014.pdf
Size:
92.48Kb
Format:
PDF
Description:
From UNPAYWALL. Conference abstract
Affiliation
Oncology and Metabolism, Academic Unit of Clinical Oncology, University of Sheffield, SheffieldIssue Date
2019
Metadata
Show full item recordCitation
Brown JE, Handforth C, Walsh J, Pezaro C, Sydes MR, Clarke NW, et al. 857P Baseline fracture risk in men with prostate cancer starting the STAMPEDE trial. Annals of Oncology. 2019;30(Supplement_5).Journal
Annals of OncologyDOI
10.1093/annonc/mdz248.014Additional Links
https://dx.doi.org/10.1093/annonc/mdz248.014Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1093/annonc/mdz248.014